BioHarvest Sciences Inc. Common Stock (BHST) — Cash Flow-to-Debt Ratio
BioHarvest Sciences Inc. Common Stock (BHST) has a Cash Flow-to-Debt Ratio of -0.11x as of June 2026, meaning its operating cash flow of $-2.77 Million could theoretically repay 0% of its total liabilities ($24.80 Million) in one year. See BioHarvest Sciences Inc. Common Stock (BHST) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioHarvest Sciences Inc. Common Stock Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for BioHarvest Sciences Inc. Common Stock across 10 annual periods. For the full cash flow conversion analysis, see BioHarvest Sciences Inc. Common Stock cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for BioHarvest Sciences Inc. Common Stock (2015–2025)
Year-by-year debt coverage analysis for BioHarvest Sciences Inc. Common Stock. Check BioHarvest Sciences Inc. Common Stock cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.33x | $-7.23 Million | $22.22 Million | ▼ -15.2% |
| 2024 | -0.28x | $-6.68 Million | $23.67 Million | ▲ +1.1% |
| 2023 | -0.29x | $-8.52 Million | $29.86 Million | ▲ +52.7% |
| 2022 | -0.60x | $-9.24 Million | $15.32 Million | ▲ +34.7% |
| 2021 | -0.92x | $-6.79 Million | $7.35 Million | ▼ -81.2% |
| 2020 | -0.51x | $-3.88 Million | $7.60 Million | ▼ -520.4% |
| 2019 | -0.08x | $-2.38 Million | $28.99 Million | ▼ -127.7% |
| 2017 | -0.04x | $-1.00K | $27.70K | ▲ +94.1% |
| 2016 | -0.62x | $-74.60K | $121.17K | ▲ +72.4% |
| 2015 | -2.23x | $-126.82K | $56.86K | — |